Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.

Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors. Acta Haematol. 2017 Sep 05;138(3):140-142 Authors: Maeda Y, Okamoto A, Kawaguchi SI, Konishi A, Yamamoto K, Eguchi G, Kanai Y, Yamaguchi T PMID: 28869927 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28869927?dopt=Abstract

Source: Acta Haematologica - September 5, 2017 Category: Hematology Authors: Maeda Y, Okamoto A, Kawaguchi SI, Konishi A, Yamamoto K, Eguchi G, Kanai Y, Yamaguchi T Tags: Acta Haematol Source Type: research

More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Hematology | Leukemia